Review of icatibant use in the Winnipeg Regional Health Authority

Abstract Background This is a retrospective review of the Winnipeg Regional Health Authority’s (WRHA) angioedema patients who were dispensed icatibant in hospital. Icatibant is a bradykinin B2 receptor antagonist indicated for Hereditary Angioedema (HAE) types I and II and is used off-label for HAE...

Full description

Bibliographic Details
Published in:	Allergy, Asthma & Clinical Immunology
Main Authors:	George Cai, Colin Barber, Chrystyna Kalicinsky
Format:	Article
Language:	English
Published:	BMC 2020-11-01
Subjects:	Icatibant Angioedema ACE-inhibitor Angiotensin-converting enzyme inhibitor Hereditary angioedema
Online Access:	http://link.springer.com/article/10.1186/s13223-020-00493-3

Similar Items

A slow and dangerous swelling of the tongue and the face
by: Erika Poggiali, et al.
Published: (2024-03-01)

Research Progress of Icatibant in the Treatment of Hereditary Angioedema
by: XU Yanhua, et al.
Published: (2025-07-01)

Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey
by: Werner Aberer, et al.
Published: (2017-07-01)

Hospitalizations due to Angioedema without Urticaria in a Portuguese Center: Five Year Retrospective Study
by: Joana Cosme, et al.
Published: (2019-11-01)

Successful use of lanadelumab in a patient with hereditary angioedema with normal C1 inhibitor and negative genetic testing
by: Adil Adatia, MD, et al.
Published: (2023-05-01)

Unraveling angioedema: diagnostic challenges and emerging therapies
by: Felix Johnson, et al.
Published: (2025-10-01)

Hereditary angioedema due to C1 inhibitor deficiency: real-world experience from the Icatibant Outcome Survey in Spain
by: Mar Guilarte, et al.
Published: (2021-12-01)

ACE inhibitor angioedema: characterization and treatment versus non-ACE angioedema in acute hospitalized patients
by: David S. Weisman, et al.
Published: (2020-01-01)

Tranexamic acid for angiotensin-converting enzyme inhibitor–induced angioedema
by: Gaurav Nitin Pathak, et al.
Published: (2024-03-01)

ACE- inhibitor induced angioedema requiring an emergency surgical airway
by: Bhargav Patel, et al.
Published: (2014-12-01)

A Rare Case of Unilateral Tongue Edema with Angiotensin Converting Enzyme Inhibitors
by: Beatriz Gil Braga, et al.
Published: (2022-07-01)

Drug-induced visceral angioedema
by: Prashanth M. Thalanayar, et al.
Published: (2014-09-01)

Treatment of patients with hereditary angioedema with the c.988A>G (p.Lys330Glu) variant in the plasminogen gene
by: Konrad Bork, et al.
Published: (2020-02-01)

Risk factors for angiotensin converting enzyme inhibitor angioedema in a South African population
by: Cascia Day, et al.
Published: (2025-10-01)

Non‐genetic factors associated with ACE‐inhibitor and angiotensin receptor blocker‐induced angioedema
by: Diana Dubrall, et al.
Published: (2025-05-01)

Five-Membered Nitrogen Heterocycles Angiotensin-Converting Enzyme (ACE) Inhibitors Induced Angioedema: An Underdiagnosed Condition
by: Niki Papapostolou, et al.
Published: (2024-03-01)

Critical angioedema induced by a renin angiotensin system blocker in the contemporary era of increasing heart failure: A case report and commentary
by: Masafumi Sato, et al.
Published: (2021-03-01)

Postoperative angioedema induced by angiotensin-converting enzyme inhibitor: case report
by: Flora Margarida Barra Bisinotto, et al.
Published: (2019-12-01)

Retrospective Evaluation of Patients with Angioedema Treated with C1 Inhibitors in an Emergency Department
by: Sercan Yalçınlı, et al.
Published: (2022-09-01)

Prediction of hereditary angioedema during attacks in patients with recurrent angioedema: Awareness at a glance with the hereditary angioedema prediction score
by: Semra Demir, et al.
Published: (2025-04-01)

Skin Reactions with Losartan and Enalapril in Cardiac Patients
by: Fariba Iraji, et al.
Published: (2012-03-01)

Bradykinin-Mediated Angioedema Induced by Commonly Used Cardiovascular Drugs
by: Janina Hahn, et al.
Published: (2023-09-01)

Angiotensin-converting enzyme inhibitor-induced angioedema: Proposal for a diagnostic score
by: Alexis Bocquet, MD, et al.
Published: (2025-03-01)

Angiotensin converting enzyme inhibitor-induced penile angioedema: A case report
by: Anthony Acosta, et al.
Published: (2025-03-01)

Acute angioedema in Cape Town emergency centres and a suggested algorithm to simplify and improve management
by: C Day, et al.
Published: (2023-08-01)

A GWAS of angiotensin-converting enzyme inhibitor-induced angioedema in a South African population
by: Jacquiline W. Mugo, PhD, et al.
Published: (2025-08-01)

Over diagnosis of bradykinin angioedema in patients treated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers
by: Marie Douillard, MD, et al.
Published: (2023-08-01)

Investigation of the correlation of C1 esterase inhibitor levels and functions with attack severity and frequency in hereditary angioedema
by: Fatma Arzu Akkuş, et al.
Published: (2024-06-01)

Navigating the swells: A case report of hereditary angioedema
by: Kamlesh Taori, et al.
Published: (2024-06-01)

Angioedema associated with dipeptidyl peptidase-IV inhibitors
by: Nicoletta Cassano, et al.
Published: (2021-12-01)

Angioedema
by: Gina Lacuesta, et al.
Published: (2024-12-01)

Clinical features of angioedema induced by renin-angiotensin-aldosterone system inhibition: a retrospective analysis of 84 patients
by: Anja Pfaue, et al.
Published: (2019-11-01)

Unrecognized recurrent perioperative angioedema requiring intubation in a patient taking long-term angiotensin-converting enzyme inhibitor therapy
by: Christopher Wojcik, et al.
Published: (2022-03-01)

Delayed angioedema during therapy with angiotensin-converting enzyme inhibitors
by: Janković Slobodan M., et al.
Published: (2011-01-01)

Abdominal attack in a patient with hereditary angioedema due to C1 inhibitor deficiency complicated by a perforated peptic ulcer
by: Piotr Obtulowicz, et al.
Published: (2024-02-01)

Icatibant, an inhibitor of bradykinin receptor 2, for hereditary angioedema attacks: prospective experimental single-cohort study
by: Regis Albuquerque Campos, et al.

ACE-ing Angioedema: A National Inpatient Sample Cohort Comparing All-cause Angioedema and ACE-I Induced Angioedema
by: Sudeep Acharya, et al.
Published: (2025-10-01)

Recurrent angioedema manifestation and treatment response in two patients from different families caring the myoferlin gene mutation: case series
by: Daria S. Fomina, et al.
Published: (2025-08-01)

Personalized biological treatment with lanadelumab in a patient with recurrent attacks of hereditary angioedema
by: Artur Gęsicki, et al.
Published: (2024-08-01)

Exercise-Induced Angioedema, Urticaria, and Anaphylaxis—A Narrative Review
by: Waleed Aman Ur Rahman, et al.
Published: (2025-07-01)